KFAS
MRNA icon

Keating Financial Advisory Services’s Moderna MRNA Stock Holding History

Keating Financial Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Buy
303
+66
+28% +$3.42K ﹤0.01% 971
2026
Q1 		$12K Buy
237
+102
+76% +$4.76K ﹤0.01% 1069
2025
Q4 		$3.98K Buy
+135
New +$3.67K ﹤0.01% 1357

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Keating Financial Advisory Services's MRNA Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Moderna (MRNA) stake by 28% in Q2 2026, buying an estimated $3.42K and bringing the position to 303 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

Keating Financial Advisory Services first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Keating Financial Advisory Services held 303 shares of Moderna worth $21.2K as of Q2 2026.
  • Keating Financial Advisory Services bought 66 Moderna shares in Q2 2026, an estimated $3.42K.
  • Moderna made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #971 holding.
  • Keating Financial Advisory Services first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.